Cyclacel Pharmaceuticals ...

NASDAQ: CYCC · Real-Time Price · USD
8.14
-0.75 (-8.44%)
At close: Aug 15, 2025, 1:27 PM

Cyclacel Pharmaceuticals Cash Flow Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Net Income
-11.21M -22.55M -21.2M -18.89M
Depreciation & Amortization
6K 31K 32K 43K
Stock-Based Compensation
592K 1.47M 1.51M 1.16M
Other Working Capital
4.47M 4.71M -3.74M -3.76M
Other Non-Cash Items
-37K -69K -967K -1.49M
Deferred Income Tax
n/a n/a 967K 1.49M
Change in Working Capital
2.66M 5.01M -1.17M -853K
Operating Cash Flow
-7.99M -16.11M -20.83M -18.54M
Capital Expenditures
n/a -6K -7K -27K
Cash Acquisitions
n/a n/a n/a n/a
Purchase of Investments
n/a n/a n/a n/a
Sales Maturities Of Investments
n/a n/a n/a n/a
Other Investing Acitivies
n/a n/a n/a n/a
Investing Cash Flow
n/a -6K -7K -27K
Debt Repayment
n/a n/a n/a n/a
Common Stock Repurchased
n/a n/a n/a n/a
Dividend Paid
n/a -201K -201K -201K
Other Financial Acitivies
1.61M n/a n/a 4.57M
Financial Cash Flow
7.82M 848K 3M 21.74M
Net Cash Flow
-241K -14.97M -18.21M 3.15M
Free Cash Flow
-7.99M -16.12M -20.83M -18.57M